Avastin's Last Hope For Breast Cancer Claim May Be Subpopulations
FDA advisory committee votes to remove the breast cancer treatment indication from the Genentech drug's label after failed confirmatory trial, but two more studies are on their way.
FDA advisory committee votes to remove the breast cancer treatment indication from the Genentech drug's label after failed confirmatory trial, but two more studies are on their way.